Protein aggregation of &#
x3b1;-synuclein (&#
x3b1;S) is a genetic and neuropathological hallmark of Parkinson's disease (PD). Studies in the model nematode Caenorhabditis elegans suggested that variation of &#
x3b1;S aggregation depends on the genetic background. However, which genes and genetic modifiers underlie individual differences in &#
x3b1;S pathology remains unknown. To study the genotypic-phenotypic relationship of &#
x3b1;S aggregation, we constructed a Recombinant Inbred Line (RIL) panel derived from a cross between genetically divergent strains C. elegans NL5901 and SCH4856, both harboring the human &#
x3b1;S gene. As a first step to discover genetic modifiers 70 &#
x3b1;S-RILs were measured for whole-genome gene expression and expression quantitative locus analysis (eQTL) were mapped. We detected multiple eQTL hot-spots, many of which were located on Chromosome V. To confirm a causal locus, we developed Introgression Lines (ILs) that contain SCH4856 introgressions on Chromosome V in an NL5901 background. We detected 74 genes with an interactive effect between &#
x3b1;S and the genetic background, including the human
p38 MAPK homologue
pmk-1 that has previously been associated with PD. Together, we present a unique &#
x3b1;S-RIL panel for defining effects of natural genetic variation on &#
x3b1;S pathology, which contributes to finding genetic modifiers of PD.